Safety and immunogenicity of a fully-liquid DTaP-IPV-Hib-HepB vaccine (Vaxelis™) in premature infants

Background: Immune immaturity may put premature infants at increased risk for infections. DTaP-IPV-Hib-HepB vaccine (Vaxelis™), a hexavalent vaccine studied in >6,800 children, has acceptable safety and immunogenicity profiles generally similar to control vaccines. Here we evaluate safety and imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilck, Marissa B., Xu, Z. Jin, Stek, Jon E., Lee, Andrew W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872088/
https://www.ncbi.nlm.nih.gov/pubmed/32750261
http://dx.doi.org/10.1080/21645515.2020.1756668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872088/
https://www.ncbi.nlm.nih.gov/pubmed/32750261
http://dx.doi.org/10.1080/21645515.2020.1756668

Ejemplares similares